- Home
- TTOO vs ETON Comparison
TTOO vs ETON Comparison
Compare TTOO & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- ETON
- Stock Information
- Founded
- TTOO 2006
- ETON 2017
- Country
- TTOO United States
- ETON United States
- Employees
- TTOO N/A
- ETON N/A
- Industry
- TTOO Medical/Dental Instruments
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- TTOO Health Care
- ETON Health Care
- Exchange
- TTOO Nasdaq
- ETON Nasdaq
- Market Cap
- TTOO 36.4M
- ETON 199.5M
- IPO Year
- TTOO 2014
- ETON 2018
- Fundamental
- Price
- TTOO $0.97
- ETON $8.77
- Analyst Decision
- TTOO Hold
- ETON Strong Buy
- Analyst Count
- TTOO 1
- ETON 3
- Target Price
- TTOO $5.00
- ETON $12.00
- AVG Volume (30 Days)
- TTOO 710.5K
- ETON 214.1K
- Earning Date
- TTOO 11-13-2024
- ETON 11-11-2024
- Dividend Yield
- TTOO N/A
- ETON N/A
- EPS Growth
- TTOO N/A
- ETON N/A
- EPS
- TTOO N/A
- ETON N/A
- Revenue
- TTOO $7,164,000.00
- ETON $31,381,000.00
- Revenue This Year
- TTOO $50.31
- ETON $19.61
- Revenue Next Year
- TTOO $117.92
- ETON $35.39
- P/E Ratio
- TTOO N/A
- ETON N/A
- Revenue Growth
- TTOO N/A
- ETON 8.14
- 52 Week Low
- TTOO $0.90
- ETON $3.03
- 52 Week High
- TTOO $8.38
- ETON $8.66
- Technical
- Relative Strength Index (RSI)
- TTOO 18.34
- ETON 76.07
- Support Level
- TTOO $0.90
- ETON $7.58
- Resistance Level
- TTOO $1.86
- ETON $8.66
- Average True Range (ATR)
- TTOO 0.15
- ETON 0.42
- MACD
- TTOO -0.00
- ETON -0.07
- Stochastic Oscillator
- TTOO 5.72
- ETON 91.49
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.